CRT 2023
Valve Imaging
Jonathan G. Schwartz, MD (he/him/his)
Medical Director, Interventional Cardiology
Sanger Heart & Vascular Institute/Atrium Health
Disclosure(s): Abbott Inc: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); Boston Scientific: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Research Study Investigator (Ongoing); Cordis Corporation: Advisor (Ongoing), Consultant/Advisory Board (Ongoing), Scientific Advisory Board (Ongoing); Edwards Lifesciences: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Honoraria (Ongoing), Scientific Research Study Investigator (Ongoing); Medtronic Inc: Advisor (Ongoing), Advisor or Review Panel Member (Ongoing), Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Scientific Research Study Investigator (Ongoing); WL Gore & Associates: Advisor (Ongoing), Scientific Research Study Investigator (Ongoing)